cached image

Ángel Baldán

Biochemistry Saint Louis University, St. Louis, MO, United States 
Molecular Biology, Biochemistry
"Ángel Baldán"

Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pauta M, Rotllan N, Fernández-Hernando A, et al. (2015) Akt-mediated FoxO1 inhibition is required for liver regeneration. Hepatology (Baltimore, Md.)
Li Y, Prasad P, Miller I, et al. (2015) Peroxisome Proliferator-Activated Receptor Alpha Contributes to Hepcidin up-Regulation in Mice during Fasting Blood. 126: 948-948
Baldan A, Gonen A, Choung C, et al. (2014) ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 193: 5637-48
Goedeke L, Salerno A, Ramírez CM, et al. (2014) Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice. Embo Molecular Medicine. 6: 1133-41
Langhi C, Marquart TJ, Allen RM, et al. (2014) Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte. Journal of Hepatology. 61: 358-65
Allen RM, Marquart TJ, Jesse JJ, et al. (2014) Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33. Circulation Research. 115: 10-22
Pauta M, Rotllan N, Vales F, et al. (2013) Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids. Journal of Hepatology. 59: 731-7
Sene A, Khan AA, Cox D, et al. (2013) Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metabolism. 17: 549-61
de Aguiar Vallim TQ, Tarling EJ, Kim T, et al. (2013) MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor. Circulation Research. 112: 1602-12
Marquart TJ, Wu J, Lusis AJ, et al. (2013) Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 455-8
See more...